Prediction of therapy failure after VEGF-based first-line treatment of kidney cancer patients by DNA hypermethylation biomarkers.
Inga Peters
No relevant relationships to disclose
Natalia Dubrowskaja
No relevant relationships to disclose
Mahmoud Abbas
No relevant relationships to disclose
Christoph Seidel
No relevant relationships to disclose
Michael Kogosov
No relevant relationships to disclose
Ralph Scherer
No relevant relationships to disclose
Kai Gebauer
No relevant relationships to disclose
Axel S. Merseburger
No relevant relationships to disclose
Markus A. Kuczyk
No relevant relationships to disclose
Viktor Grünwald
No relevant relationships to disclose
Juergen Serth
No relevant relationships to disclose